8:17am PDT - June 5th, 2023
RT @TiansterZhang: Phase 3 #THOR trial reading out means erdafitinib is the RIGHT life extending option for patients with #FGFR alterations…
0 retweets 2 likes - Paulo G Bergerot (@PauloBergerot)RT @TiansterZhang: Phase 3 #THOR trial reading out means erdafitinib is the RIGHT life extending option for patients with #FGFR alterations…
0 retweets 2 likes - Paulo G Bergerot (@PauloBergerot)